The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of EGFR CA simple sequence repeat 1 (CA-SSR1) variant with cetuximab (cet)-induced skin toxicity (ST) in Japanese metastatic colorectal cancer (mCRC) patients (pts) with overexpressed EGFR and KRAS exon 2 wild-type (KRAS wt) (JACCRO CC-05/06 AR).
 
Wataru Ichikawa
Honoraria - Bristol-Myers Squibb; Merck Serono; Taiho Pharmaceutical
Consulting or Advisory Role - Daiichi Sankyo; Merck Serono
 
Yu Sunakawa
Honoraria - Takeda
 
Akihito Tsuji
Honoraria - Taiho Pharmaceutical
 
Takehiro Takahashi
No Relationships to Disclose
 
Tadamichi Denda
No Relationships to Disclose
 
Ken Shimada
No Relationships to Disclose
 
Mitsugu Kochi
No Relationships to Disclose
 
Masato Nakamura
Honoraria - Chugai Pharma; Taiho Pharmaceutical
 
Masahito Kotaka
No Relationships to Disclose
 
Yoshihiko Segawa
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Taiho Pharmaceutical (Inst)
 
Hiroaki Tanioka
No Relationships to Disclose
 
Yuji Negoro
No Relationships to Disclose
 
Akinori Takagane
No Relationships to Disclose
 
Satoshi Tani
No Relationships to Disclose
 
Tatsuro Yamaguchi
Speakers' Bureau - Bristol-Myers Squibb; Chugai Pharma; Taiho Pharmaceutical; Yakult Pharmaceutical
 
Toshiki Masuishi
No Relationships to Disclose
 
Masahiro Takeuchi
Honoraria - Takeda
Consulting or Advisory Role - AstraZeneca; Hisamitsu Pharmaceutical; Shionogi; Taiho Pharmaceutical
 
Heinz-Josef Lenz
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Merck KGaA; Vela Diagnostics
Research Funding - Bristol-Myers Squibb; Genentech; Merck KGaA; Novartis
 
Masashi Fujii
Stock and Other Ownership Interests - Otsuka (I)
Consulting or Advisory Role - Taiho Pharmaceutical
Travel, Accommodations, Expenses - Japan Clinical Cancer Research Organization
 
Toshifusa Nakajima
No Relationships to Disclose